NLRP3 and esophageal squamous cell carcinoma: Finally, in vitro and in vivo experiments were conducted to study the overall molecular mechanism by which Fn can activate NLRP3 in ESCC cells to cause the massive enrichment of MDSCs and lead to CDDP treatment resistance.